COVID-19 and immunomodulation treatment for women with reproductive failuresReview Article Published on 2020-06-122023-07-01 Journal: Journal of reproductive immunology [Category] SARS, [키워드] COVID-19 Immunotherapy Pregnancy reproductive failure SARS-CoV-2 [DOI] 10.1016/j.jri.2020.103168 PMC 바로가기 [Article Type] Review Article
Effects of COVID-19 Infection during Pregnancy and Neonatal Prognosis: What Is the Evidence?Review Published on 2020-06-112022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] addition biological sample C-section Care clinical condition Comorbidity concerning Contact COVID-19 COVID-19 infection database Effect eligible Evidence fetal fetal transmission Health Infant infected with SARS-CoV-2 Infection knowledge lack literature review Mother-to-child transmission Neonatal nine Occurrence positive potential risk Pregnancy pregnant women presenting provided question respiratory disorders SARS-CoV-2 tested Transmission worsening [DOI] 10.3390/ijerph17114176 PMC 바로가기 [Article Type] Review
Hepatitis E virus infection during pregnancyReview Published on 2020-06-102023-05-23 Journal: Virology Journal [Category] E형 간염, Fulltext, [키워드] hepatitis E Hepatitis E virus (HEV) Pregnancy [DOI] 10.1186/s12985-020-01343-9 PMC 바로가기 [Article Type] Review
Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort studyResearch Published on 2020-06-082022-10-28 Journal: The BMJ [Category] COVID-19, Fulltext, SARS, [키워드] 95% confidence interval acute respiratory syndrome Admission Cohort cohort study Comorbidities coronavirus Critical care death died ethnic group Factor fetal FIVE groups Guidance hospital Hospital admission identify incidence Infant Infants Infection ISRCTN MOST mother National Neonatal obese objective obstetric unit outcome outcome measure outcomes participant positive Pregnancy pregnant women Preterm birth proportion Prospective Rate Respiratory Support Result SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA setting Social distancing measure Stillbirth System tested Transmission transmission of SARS-CoV-2 urgent investigation women [DOI] 10.1136/bmj.m2107 PMC 바로가기 [Article Type] Research
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialLetter Published on 2020-06-082022-10-29 Journal: Trials [Category] COVID-19, SARS, [키워드] activity adverse event allergic reaction anti-SARS-CoV-2 anti-SARS-CoV-2 antibody Anti-SARS-CoV-2 plasma Anti-viral blinded Blood blood product center Chest radiography Clinical improvement Clinical outcome clinical status clinical trial clinician collected Columbia University control arm convalescent plasma coronavirus COVID-19 COVID-19 symptom criteria cumulative Date defined Dilution discharge dissemination Donor ECMO Efficacy Efficacy and safety element evaluate Evaluating Evidence extracorporeal membrane oxygenation hazard hazard ratio HBV HCV HIV hospital Hospitalized hospitalized patient IgA deficiency immune incidence include Infection Influenza Invasive mechanical ventilation mechanical ventilation multi-organ failure nasopharyngeal Nasopharyngeal swab New York Non-invasive number objective occur oropharyngeal swab outcome oxygen saturation participant Participants patients hospitalized PCR test PCR-negative per-protocol analysis peripheral capillary plasma platform post-hoc analysis Pregnancy primary endpoint protocol randomization Randomized Randomized controlled trial randomized, controlled trial randomly permuted block receive Registered Remdesivir requiring high-flow oxygen requiring supplemental oxygen Research Respiratory failure retrospective Ritonavir safety endpoint Sample size SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection screened Serious Adverse Event seven-point ordinal scale severe COVID-19 severe SARS-CoV-2 severely ill adult single-center spike trimer SpO2 status study participant study period Study protocol supplemental oxygen tested therapy transfused Treatment treatment for COVID-19 Trial undergo USA Version Volunteer Wald test website with COVID-19 World Health Organization ZIKV [DOI] 10.1186/s13063-020-04422-y PMC 바로가기 [Article Type] Letter
Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional studyResearch Article Published on 2020-06-052023-06-02 Journal: BMC Infectious Diseases [Category] B형 간염, [키워드] hepatitis B Pregnancy Tanzania vertical transmission [DOI] 10.1186/s12879-020-05096-2 PMC 바로가기 [Article Type] Research Article
Maternal and neonatal outcomes associated with COVID-19 infection: A systematic reviewCOVID-19 감염과 관련된 산모 및 신생아 결과: 체계적인 검토Research Article Published on 2020-06-042022-08-13 Journal: PLoS ONE [Category] Biology and Life Sciences, COVID-19, MERS, SARS, [키워드] analysed Analysis articles Birth weight C-section Caesarean section clinician COVID-19 COVID-19-positive pregnant women criteria CT-based diagnosis Data collection distress during pregnancy Effect eligible English evaluate fetal fetal distress for inclusion General population Health Health crisis Hypothesis testing ICROMS tool incidence intensive care Low birth weight Maternal Maternal mortality rate Neonatal Neonate Neonates NICU NICU admission nine no difference objective outcome outcomes Patient Pneumonia Pregnancy preterm births reported required RT-PCR searched Selection Symptom symptomatic systematic review time-to-delivery Transmission Ventilation vertical transmission Viral Viral pneumonia was performed with COVID-19 women [DOI] 10.1371/journal.pone.0234187 PMC 바로가기 [Article Type] Research Article
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-06-032022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 95% CI absence addition administration of hydroxychloroquine Admission aerosol-generating procedures allergy analyzed Anesthesia antibody approved ARMS assigned balanced randomization blind Cancer Cantabria carried CDC Cell Chemoprophylaxis clinical Clinical data clinically coated Committee comparator Comparator group computer-generated control group Controlled Controlled clinical trial Controlled trial coronavirus COVID COVID-19 criteria CURB current detect Determination disease dissemination double blind double-blind dropout rate Efficacy Efficacy and safety element ELISA kit Emergency Endocrine estimate Ethics Euroimmun Evidence evidence of Germany GRADE greater group Health Health authority health-care healthcare personnel Healthcare professional healthcare professionals heart heart failure help hematological high risk hospital Hydroxychloroquine hydroxychloroquine sulfate hygiene Hypothesis ICU IDT IgA IgG IgM and IgG immune immunodeficiency in vitro incidence include Infection inhibit intensive care unit Intervention investigator kidney lactation liver measure Measures Medicine Negative PCR neurological New York number observation period outcome participant PCR performed Personal protective equipment Placebo positive positive SARS-CoV-2 PCR positive serology Pregnancy presenting Prevalence Primary outcome probes product professional Prophylaxis Prospective PROTECT Protective protocol Psychiatric randomised randomised controlled trial randomization Randomized randomized trial RCT receive recruitment reduce reported responsible risk RT-PCR Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR sequence Seroconversion serological serology severity Significant single center single-center study social distancing Spain Spanish Standard Statistical power status Study protocol subject Support Symptom symptomatic and asymptomatic Tablet Takara Taking Tamoxifen Transmission Treatment two-tailed university Vaccine virus website while [DOI] 10.1186/s13063-020-04400-4 PMC 바로가기 [Article Type] Letter
Clinical characteristics and outcomes of COVID-19 infection in nine pregnant women: a report from a sub-Saharan African country, Senegal9명의 임산부를 대상으로 한 코로나19 감염의 임상적 특징과 결과: 사하라 사막 이남의 아프리카 국가, 세네갈의 보고서Research Published on 2020-06-022022-09-01 Journal: The Pan African Medical Journal [Category] MERS, 진단, [키워드] Admission African age All the patient all the patients association average Characteristics clinical Clinical characteristics clinical feature Clinical features Contamination coronavirus cough country COVID-19 COVID-19 infection COVID-19 pneumonia cross-sectional Data collection died Evidence Fever Frequency General population headache hospital Infection median time nine Other outcome Patient PCR predisposition Pregnancy pregnant pregnant women reported Result rhinorrhea SARS-CoV-2 SARS-COV-2 infection Senegal Severe COVID-19 pneumonia susceptible Symptom the patient Treatment two patients underlying diseases women [DOI] 10.11604/pamj.supp.2020.35.2.23736 PMC 바로가기 [Article Type] Research
Pattern and interpretation of hepatitis B virus markers among pregnant women in North East EgyptArticle Published on 2020-06-012023-06-13 Journal: Brazilian journal of microbiology : [publication o [Category] B형 간염, [키워드] Egypt HBV Hepatitis markers Pregnancy vaccination [DOI] 10.1007/s42770-019-00174-3 PMC 바로가기